
11 - 50 employees
Founded 2026
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Atrium Therapeutics is a clinical-stage biotechnology company developing precision RNA medicines targeted to the heart. The company has a proprietary RNA delivery platform built on clinically validated AOC (antibody-oligonucleotide conjugate) technology originally designed at Avidity Biosciences, enabling delivery of oligonucleotide therapies directly into cardiac muscle while addressing cytotoxicity, immunogenicity, and redosing limitations. Atrium's pipeline includes lead candidates ATR-1072 for PRKAG2 syndrome and ATR-1086 for PLN cardiomyopathy, plus additional research-stage targets in rare cardiomyopathies; the company plans to file an IND for ATR-1072 in the second half of 2026. Atrium positions itself to pioneer precision cardiology by bringing RNA therapeutics to patients with genetic and rare forms of heart disease.
🔥 13 hours ago
Where this job comes from
Posted on Atrium Therapeutics's careers page, not through a job board
First seen by Remote Rocketship 13 hours ago
Still open on Atrium Therapeutics's site. Checked 46 minutes ago.

11 - 50 employees
Founded 2026
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Atrium Therapeutics is a clinical-stage biotechnology company developing precision RNA medicines targeted to the heart. The company has a proprietary RNA delivery platform built on clinically validated AOC (antibody-oligonucleotide conjugate) technology originally designed at Avidity Biosciences, enabling delivery of oligonucleotide therapies directly into cardiac muscle while addressing cytotoxicity, immunogenicity, and redosing limitations. Atrium's pipeline includes lead candidates ATR-1072 for PRKAG2 syndrome and ATR-1086 for PLN cardiomyopathy, plus additional research-stage targets in rare cardiomyopathies; the company plans to file an IND for ATR-1072 in the second half of 2026. Atrium positions itself to pioneer precision cardiology by bringing RNA therapeutics to patients with genetic and rare forms of heart disease.
• Lead the pharmacokinetics and pharmacodynamics function at Atrium Therapeutics • Support all aspects of PKPD across programs from research into late-phase clinical development • Design, oversee, and interpret nonclinical and clinical PK, TK, and tissue distribution studies • Apply PKPD principles to relate exposure to target engagement and PD biomarkers • Inform dose selection and support first-in-human dose rationale • Assess immunogenicity impact on PK where relevant • Set phase-appropriate bioanalytical strategy • Oversee development of GLP-compliant PK and ADA assays in plasma and tissue matrices • Oversee CRO management, including RFP, SOWs, budget, timeline, and sample logistics • Represent PKPD on project and study teams • Communicate PKPD strategy and data interpretation • Support regulatory documents, including IND/CTA, briefing book, protocol, and CSR • Manage, mentor, and develop a team of PhD and non-PhD scientists • Set priorities, support career development, and build a collaborative, high-performing culture
• PhD in Pharmacokinetics, Pharmaceutical Sciences, Pharmacology, Analytical Chemistry, Biochemistry, or a related field • 8+ years of biopharma/biotech experience in nonclinical and clinical PKPD and regulated bioanalysis • Proven record of advancing programs from research into development • Experience authoring/supporting IND submissions and participating in regulatory interactions • Hands-on design and interpretation of nonclinical and clinical PK studies, including NCA • Strong understanding of PKPD principles • Working knowledge of regulated bioanalysis (ICH M10, GLP/GCP) • Experience overseeing PK and ADA assay development and sample analysis at CROs • Prior experience managing and developing scientific staff at multiple levels, including PhD and non-PhD scientists • Demonstrated ability to lead cross-functional initiatives and communicate complex data clearly to project teams and leadership • Comfortable with ambiguity, takes initiative, and is a hands-on problem-solver • Oligonucleotide (siRNA, ASO) and/or large-molecule experience preferred
• Stock options & RSUs • 401(k) with an employer match • Wellness program • Medical coverage • Dental coverage • Vision coverage • LTD coverage • Unlimited time off, including summer & winter breaks • Learning and development programming internally developed by and for Atrium employees • Job-specific training offered by industry • Education reimbursement program
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 13 hours ago
Associate Director shaping CNS Medical Affairs strategy for Otsuka pharmaceutical assets. Leading evidence generation, scientific communications, cross-functional execution, and strategic content review.
🔥 15 hours ago
US Oncology Patient Channel Strategist shaping data-driven media strategies for Merck’s medicines and vaccines. Guiding targeting, measurement, optimization, and patient marketing performance.
🔥 16 hours ago
Senior Director building Coca-Cola Consolidated’s integrated beverage commercial execution system. Connecting strategy, bottler adoption, field execution, and marketplace growth.
🔥 16 hours ago
Strategic account director driving Honeywell’s automation solutions, revenue, and executive partnerships with semiconductor customers across North America. Leading global teams and complex enterprise negotiations.
🔥 18 hours ago
Senior Director leading Coca-Cola bottler transformation, operating-model redesign, and adoption. Driving measurable growth, efficiency, and capability building across U.S. markets.